Clinical Trial Update: Prevalence and Impact in Work Productivity of Gastroesophageal Reflux Disease (GERD) in Primary Care Patients With Upper Gastrointestinal (GI) Symptoms Using GerdQ

View source ↗

Summary

This completed AstraZeneca-sponsored clinical trial update examines the prevalence of gastroesophageal reflux disease and its impact on work productivity in pri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux Disease | Status: COMPLETED